TrialVaccine2020

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age.

Lulu C Bravo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.